SG11201508453YA - Pharmaceutical composition and uses thereof - Google Patents

Pharmaceutical composition and uses thereof

Info

Publication number
SG11201508453YA
SG11201508453YA SG11201508453YA SG11201508453YA SG11201508453YA SG 11201508453Y A SG11201508453Y A SG 11201508453YA SG 11201508453Y A SG11201508453Y A SG 11201508453YA SG 11201508453Y A SG11201508453Y A SG 11201508453YA SG 11201508453Y A SG11201508453Y A SG 11201508453YA
Authority
SG
Singapore
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
SG11201508453YA
Other languages
English (en)
Inventor
Pei-Chang Wu
Chueh-Tan Chen
Chia-Ling Tsai
Original Assignee
Kaohsiung Chang Gung Memorial Hospital
Wu Philip
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaohsiung Chang Gung Memorial Hospital, Wu Philip filed Critical Kaohsiung Chang Gung Memorial Hospital
Publication of SG11201508453YA publication Critical patent/SG11201508453YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11201508453YA 2013-05-06 2014-05-05 Pharmaceutical composition and uses thereof SG11201508453YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361819709P 2013-05-06 2013-05-06
PCT/US2014/036810 WO2014182620A1 (fr) 2013-05-06 2014-05-05 Composition pharmaceutique et utilisations de celle-ci

Publications (1)

Publication Number Publication Date
SG11201508453YA true SG11201508453YA (en) 2015-11-27

Family

ID=51867665

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201508453YA SG11201508453YA (en) 2013-05-06 2014-05-05 Pharmaceutical composition and uses thereof

Country Status (11)

Country Link
US (3) US20160067238A1 (fr)
EP (1) EP2994197B1 (fr)
JP (2) JP6208332B2 (fr)
KR (2) KR102027663B1 (fr)
CN (1) CN105555363B (fr)
CA (2) CA2911298C (fr)
ES (1) ES2871116T3 (fr)
HK (1) HK1219691A1 (fr)
SG (1) SG11201508453YA (fr)
TW (2) TWI562776B (fr)
WO (1) WO2014182620A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9421199B2 (en) 2014-06-24 2016-08-23 Sydnexis, Inc. Ophthalmic composition
US11382909B2 (en) 2014-09-05 2022-07-12 Sydnexis, Inc. Ophthalmic composition
CN107847432A (zh) 2015-05-29 2018-03-27 西德奈克西斯公司 D2o稳定化的药物制剂
SG11201910085UA (en) 2017-05-11 2019-11-28 Nevakar Inc Atropine pharmaceutical compositions
BR112020001170A2 (pt) 2017-07-20 2020-07-21 Alan Laboratories, Inc. composição e métodos para o tratamento de miopia
WO2019143777A1 (fr) * 2018-01-17 2019-07-25 Eyenovia, Inc. Méthodes et dispositifs pour administrer de l'atropine à un œil sous la forme d'un flux microdosé de gouttelettes

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01226313A (ja) * 1988-03-07 1989-09-11 Toyota Motor Corp 樹脂成形品の製造方法
US4938949A (en) 1988-09-12 1990-07-03 University Of New York Treatment of damaged bone marrow and dosage units therefor
KR920002149A (ko) * 1990-07-03 1992-02-28 안드레아 엘. 콜비 비스테로이드계 소염제에 의해 유발된 위장 장애 증상을 완화시키기 위한 약제 조성물 및 이를 완화시키는 방법
JP2000026313A (ja) * 1998-05-06 2000-01-25 Hokuriku Seiyaku Co Ltd 消化管運動抑制剤
SE0002211D0 (sv) * 2000-06-13 2000-06-13 Synphora Ab Methods and compositions for prevention of myopia
ITMI20010733A1 (it) 2001-04-05 2002-10-05 Recordati Chem Pharm Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria
JP2006504661A (ja) * 2002-07-30 2006-02-09 オメロス コーポレイション 眼科学的洗浄溶液および眼科学的洗浄方法
DE60332387D1 (de) 2002-12-13 2010-06-10 Warner Lambert Co Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege
WO2006041942A2 (fr) 2004-10-04 2006-04-20 Qlt Usa, Inc. Apport oculaire de preparations d'apport polymere
CN1302812C (zh) 2004-11-30 2007-03-07 中国海洋大学 含海藻糖和玻璃酸的眼部用药传递系统及其制备方法
US20070254914A1 (en) * 2006-05-01 2007-11-01 Non-Profit Organization Chang Gung Memorial Hospital Low-concentration atropine solution for preventing myopia progression and preparing method thereof
US7939544B2 (en) 2007-09-25 2011-05-10 Abbott Laboratories Octahydropentalene compounds as chemokine receptor antagonists
EP2247289A4 (fr) * 2008-02-21 2011-05-04 Ista Pharmaceuticals Ains ophtalmiques utilisés comme adjuvants
US9046699B2 (en) 2012-03-13 2015-06-02 Johnson & Johnson Vision Care, Inc. Dynamic fluid zones in contact lenses
US10688041B2 (en) * 2012-05-03 2020-06-23 Kala Pharmaceuticals, Inc. Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
KR101953736B1 (ko) 2012-05-21 2019-03-04 디씨비-유에스에이 엘엘씨 제브라피시 모델을 사용한 약물 스크리닝 방법 및 이 방법으로 스크린된 화합물
US9827250B2 (en) * 2012-07-31 2017-11-28 Johnson & Johnson Vision Care, Inc. Lens incorporating myopia control optics and muscarinic agents

Also Published As

Publication number Publication date
CN105555363A (zh) 2016-05-04
US10888556B2 (en) 2021-01-12
TW201641105A (zh) 2016-12-01
CA2911298C (fr) 2019-09-17
TWI562776B (en) 2016-12-21
KR102027663B1 (ko) 2019-10-01
ES2871116T3 (es) 2021-10-28
TW201446245A (zh) 2014-12-16
US10548887B2 (en) 2020-02-04
CA3050457C (fr) 2021-05-25
CN105555363B (zh) 2019-03-12
EP2994197A4 (fr) 2016-12-28
KR20170094552A (ko) 2017-08-18
EP2994197B1 (fr) 2021-04-28
EP2994197A1 (fr) 2016-03-16
US20160067238A1 (en) 2016-03-10
TWI617306B (zh) 2018-03-11
JP6450814B2 (ja) 2019-01-09
JP2018008991A (ja) 2018-01-18
WO2014182620A1 (fr) 2014-11-13
JP2016518410A (ja) 2016-06-23
KR20160004288A (ko) 2016-01-12
CA3050457A1 (fr) 2014-11-13
CA2911298A1 (fr) 2014-11-13
HK1219691A1 (zh) 2017-04-13
US20200113890A1 (en) 2020-04-16
JP6208332B2 (ja) 2017-10-04
US20180311227A1 (en) 2018-11-01

Similar Documents

Publication Publication Date Title
HK1223975A1 (zh) 含納米氣泡的組合物及其用途
ZA201602510B (en) Strigolactone formulations and uses thereof
HUE046964T2 (hu) Kombinált gyógyászati készítmény
IL240290B (en) History of pyridazinone-amide and pharmaceutical preparations containing them
GB201317286D0 (en) Composition and Use
HK1220920A1 (zh) 治療性組合物和其用途
HK1222563A1 (zh) 藥物組合物、製備及其用途
GB201321693D0 (en) Composition and uses thereof
EP2990038A4 (fr) Composition pharmaceutique solide
PT3058936T (pt) Composição peptídica e respetivos usos
IL276126B (en) Preparations containing l-4-chloroquinonerine and their uses
HK1219691A1 (zh) 醫藥組成物及其用途
EP2995308A4 (fr) Composition médicinale anti-anoxie et son application
EP3007720A4 (fr) Composition comprenant le facteur d'activation des macrophages gc et utilisations associées
SG11201601477VA (en) Pharmaceutical composition
GB201301979D0 (en) New composition and use thereof
GB201307082D0 (en) Pharmaceutical composition comprising 15-HETrE and methods of using the same
IL240177A (en) Chromium-6-Iloxy-cycloalkanes are conserved and used as drugs
HUP1300496A2 (hu) Stabil kombinációs gyógyszerkészítmény
HK1220143A1 (zh) 藥物組合物
ZA201601880B (en) Hetero-transglycosylase and uses thereof
IL284405A (en) Pharmaceutical composition, preparation and uses thereof
GB201301022D0 (en) Composition and uses thereof
GB201322467D0 (en) Composition and use
GB201308242D0 (en) Compositions and uses thereof